{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:43:31Z","timestamp":1792457011074,"version":"4.5.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000038","name":"NSERC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004819","name":"Egypt Ministry of Higher Education Cultural Affairs and Missions Sector","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008572","name":"University of Ottawa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008572","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.bioorg.2021.104965","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T22:23:19Z","timestamp":1620166999000},"page":"104965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site"],"prefix":"10.1016","volume":"112","author":[{"given":"Ibrahim H.","family":"Eissa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Dahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed K.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawaf A.","family":"Alsaif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.Z.","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally I.","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed B.M.","family":"Mehany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 M.","family":"Beauchemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2021.104965_b0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/iub.25","article-title":"Microtubules: A dynamic target in cancer therapy","volume":"60","author":"Pasquier","year":"2008","journal-title":"IUBMB Life"},{"issue":"1","key":"10.1016\/j.bioorg.2021.104965_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568011023354290","article-title":"Mechanism of action of antitumor drugs that interact with microtubules and tubulin","volume":"2","author":"Jordan","year":"2002","journal-title":"Curr Med Chem Anticancer Agents"},{"issue":"3","key":"10.1016\/j.bioorg.2021.104965_b0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine-Update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Seminars in arthritis and rheumatism"},{"issue":"5","key":"10.1016\/j.bioorg.2021.104965_b0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/ar2039","article-title":"Colchicine in acute gouty arthritis: the optimum dose?","volume":"8","author":"Varughese","year":"2006","journal-title":"Arthritis research & therapy"},{"issue":"10","key":"10.1016\/j.bioorg.2021.104965_b0025","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.clinthera.2014.07.017","article-title":"Mechanism of action of colchicine in the treatment of gout","volume":"36","author":"Dalbeth","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.bioorg.2021.104965_b0030","doi-asserted-by":"crossref","unstructured":"Restrepo-Escobar, M., M.d.J. Carmona-Franceschi, and J.H. Donado G\u00f3mez, Colchicine treatment in adult patients with knee osteoarthritis: Systematic review of the literature. Revista Colombiana de Reumatolog\u00eda (English Edition), 2017. 24(2): p. 102-111.","DOI":"10.1016\/j.rcreue.2017.01.002"},{"issue":"3","key":"10.1016\/j.bioorg.2021.104965_b0035","doi-asserted-by":"crossref","first-page":"31957","DOI":"10.3402\/jchimp.v6.31957","article-title":"Effects of colchicine on pericardial diseases: a review of the literature and current evidence","volume":"6","author":"Shah","year":"2016","journal-title":"Journal of community hospital internal medicine perspectives"},{"issue":"6","key":"10.1016\/j.bioorg.2021.104965_b0040","doi-asserted-by":"crossref","first-page":"702","DOI":"10.2174\/1381612824666180116101823","article-title":"The Role of Colchicine in Pericardial Syndromes","volume":"24","author":"Lazaros","year":"2018","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.bioorg.2021.104965_b0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2174\/1871525717666181211110332","article-title":"The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia","volume":"16","author":"Spartalis","year":"2018","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"1","key":"10.1016\/j.bioorg.2021.104965_b0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clinthera.2018.11.016","article-title":"Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview","volume":"41","author":"Nidorf","year":"2019","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.bioorg.2021.104965_b0055","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.jtice.2014.07.016","article-title":"The discovery of potential tubulin inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies","volume":"45","author":"Niu","year":"2014","journal-title":"Journal of the Taiwan Institute of Chemical Engineers"},{"issue":"9","key":"10.1016\/j.bioorg.2021.104965_b0060","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1365-2362.1992.tb01516.x","article-title":"Colchicine analogues: effect on amyloidogenesis in a murine model and in vitro, on polymorphonuclear leukocytes","volume":"22","author":"Wolach","year":"1992","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.1016\/j.bioorg.2021.104965_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087064","article-title":"Novel analogue of colchicine induces selective pro-death autophagy and necrosis in human cancer cells","volume":"9","author":"Larocque","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bioorg.2021.104965_b0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/med.2610080105","article-title":"Colchicine and its analogues: Recent findings","volume":"8","author":"Brossi","year":"1988","journal-title":"Medicinal Research Reviews"},{"issue":"19","key":"10.1016\/j.bioorg.2021.104965_b0075","doi-asserted-by":"crossref","first-page":"10618","DOI":"10.1021\/acs.jmedchem.0c00222","article-title":"Colchicine Alkaloids and Synthetic Analogues: Current Progress and Perspectives","volume":"63","author":"Gracheva","year":"2020","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2021.104965_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113058","article-title":"Discovery of novel CA-4 analogs as dual inhibitors of tubulin polymerization and PD-1\/PD-L1 interaction for cancer treatment","volume":"213","author":"Yang","year":"2021","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/j.bioorg.2021.104965_b0085","article-title":"Colchicine-Binding Site Inhibitors from Chemistry to Clinic","volume":"13","author":"McLoughlin","year":"2020","journal-title":"A Review. Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.bioorg.2021.104965_b0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/ph13010008","article-title":"Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review","volume":"13","author":"McLoughlin","year":"2020","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.bioorg.2021.104965_b0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2613.2002.00211.x","article-title":"The biology of the combretastatins as tumour vascular targeting agents","volume":"83","author":"Tozer","year":"2002","journal-title":"International journal of experimental pathology"},{"issue":"17","key":"10.1016\/j.bioorg.2021.104965_b0100","first-page":"6413","article-title":"Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability","volume":"61","author":"Tozer","year":"2001","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.bioorg.2021.104965_b0105","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrc1628","article-title":"Disrupting tumour blood vessels","volume":"5","author":"Tozer","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"10.1016\/j.bioorg.2021.104965_b0110","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.3390\/molecules25112560","article-title":"Combretastatins: An Overview of Structure, Probable Mechanisms of Action and Potential Applications","volume":"25","author":"Karatoprak","year":"2020","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"4","key":"10.1016\/j.bioorg.2021.104965_b0115","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1158\/1078-0432.CCR-0518-03","article-title":"Comparative Preclinical Pharmacokinetic and Metabolic Studies of the Combretastatin Prodrugs Combretastatin A4 Phosphate and A1 Phosphate","volume":"10","author":"Kirwan","year":"2004","journal-title":"Clinical Cancer Research"},{"issue":"12","key":"10.1016\/j.bioorg.2021.104965_b0120","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1124\/dmd.107.016998","article-title":"In Vitro Metabolism Study of Combretastatin A-4 in Rat and Human Liver Microsomes","volume":"35","author":"Aprile","year":"2007","journal-title":"Drug Metabolism and Disposition"},{"issue":"8","key":"10.1016\/j.bioorg.2021.104965_b0125","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.3390\/molecules16086684","article-title":"3D-QSAR Study of Combretastatin A-4 Analogs Based on Molecular Docking","volume":"16","author":"Jin","year":"2011","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2021.104965_b0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0014-5793(83)80729-7","article-title":"Interaction of colchicine analogues with purified tubulin","volume":"161","author":"Choudhury","year":"1983","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bioorg.2021.104965_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104265","article-title":"Design, synthesis, and anticancer evaluation of benzophenone derivatives bearing naphthalene moiety as novel tubulin polymerization inhibitors","volume":"104","author":"Wang","year":"2020","journal-title":"Bioorganic Chemistry"},{"key":"10.1016\/j.bioorg.2021.104965_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112519","article-title":"Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities","volume":"202","author":"Li","year":"2020","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"8","key":"10.1016\/j.bioorg.2021.104965_b0145","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1021\/acsmedchemlett.0c00278","article-title":"Synthesis, Biological Evaluation, and Molecular Docking of Arylpyridines as Antiproliferative Agent Targeting Tubulin","volume":"11","author":"He","year":"2020","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"10.1016\/j.bioorg.2021.104965_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112328","article-title":"Ligand- and structural-based discovery of potential small molecules that target the colchicine site of tubulin for cancer treatment","volume":"196","author":"Guo","year":"2020","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2021.104965_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112105","article-title":"Synthesis and biological evaluation of novel shikonin-benzo[b]furan derivatives as tubulin polymerization inhibitors targeting the colchicine binding site","volume":"190","author":"Shao","year":"2020","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"19","key":"10.1016\/j.bioorg.2021.104965_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115684","article-title":"A 2-step synthesis of Combretastatin A-4 and derivatives as potent tubulin assembly inhibitors","volume":"28","author":"Barnes","year":"2020","journal-title":"Bioorganic & Medicinal Chemistry"},{"issue":"3","key":"10.1016\/j.bioorg.2021.104965_b0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ml200149g","article-title":"A-ring dihalogenation increases the cellular activity of combretastatin-templated tetrazoles","volume":"3","author":"Beale","year":"2012","journal-title":"ACS Med Chem Lett"},{"issue":"2","key":"10.1016\/j.bioorg.2021.104965_b0170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1021\/acsmedchemlett.6b00427","article-title":"Combretastatin A4-\u03b2-Galactosyl Conjugates for Ovarian Cancer Prodrug Monotherapy","volume":"8","author":"Doura","year":"2017","journal-title":"ACS Med Chem Lett"},{"issue":"6","key":"10.1016\/j.bioorg.2021.104965_b0175","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ejmech.2004.12.008","article-title":"Synthesis and evaluation of double bond substituted combretastatins","volume":"40","author":"Hadfield","year":"2005","journal-title":"Eur J Med Chem"},{"issue":"3","key":"10.1016\/j.bioorg.2021.104965_b0180","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1021\/jm049622b","article-title":"Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines","volume":"48","author":"Simoni","year":"2005","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.bioorg.2021.104965_b0185","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.ejmech.2007.11.030","article-title":"1,2,3,4-tetrahydro-2-thioxopyrimidine analogs of combretastatin-A4","volume":"43","author":"Lee","year":"2008","journal-title":"Eur J Med Chem"},{"issue":"25","key":"10.1016\/j.bioorg.2021.104965_b0190","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1021\/jm020291h","article-title":"A new series of estrogen receptor modulators that display selectivity for estrogen receptor beta","volume":"45","author":"Henke","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bioorg.2021.104965_b0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejmech.2017.09.063","article-title":"Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues","volume":"141","author":"Mustafa","year":"2017","journal-title":"Eur J Med Chem"},{"issue":"24","key":"10.1016\/j.bioorg.2021.104965_b0200","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1016\/j.bmcl.2009.10.064","article-title":"Synthesis and antitumor-evaluation of cyclopropyl-containing combretastatin analogs","volume":"19","author":"F\u00fcrst","year":"2009","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"8","key":"10.1016\/j.bioorg.2021.104965_b0205","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1021\/jm010523x","article-title":"Potent, orally active heterocycle-based combretastatin A-4 analogues: synthesis, structure-activity relationship, pharmacokinetics, and in vivo antitumor activity evaluation","volume":"45","author":"Wang","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bioorg.2021.104965_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112625","article-title":"Synthesis, and biological evaluation of 3,6-diaryl-[1,2,4]triazolo[4,3-a]pyridine analogues as new potent tubulin polymerization inhibitors","volume":"204","author":"Yang","year":"2020","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2021.104965_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103260","article-title":"Novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities","volume":"92","author":"Yang","year":"2019","journal-title":"Bioorganic Chemistry"},{"key":"10.1016\/j.bioorg.2021.104965_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104076","article-title":"Synthesis and biological evaluation of benzofuran-based 3,4,5-trimethoxybenzamide derivatives as novel tubulin polymerization inhibitors","volume":"102","author":"Li","year":"2020","journal-title":"Bioorganic Chemistry"},{"issue":"3","key":"10.1016\/j.bioorg.2021.104965_b0225","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0223-5234(02)01339-9","article-title":"Pyrrolo[2,1-c][1,2,4]triazines from 2-diazopyrroles: synthesis and antiproliferative activity","volume":"37","author":"Diana","year":"2002","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.bioorg.2021.104965_b0230","first-page":"3775","article-title":"Synthesis and antiproliferative activity of [1,2,4]triazino [4,3-a] indoles","volume":"24","author":"Barraja","year":"2004","journal-title":"Anticancer Res"},{"issue":"12","key":"10.1016\/j.bioorg.2021.104965_b0235","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ejmech.2006.06.013","article-title":"Novel derivatives of methyl and ethyl 2-(4-oxo-8-aryl-2H-3,4,6,7-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetates from biologically active 1-aryl-2-hydrazinoimidazolines: synthesis, crystal structure and antiproliferative activity","volume":"41","author":"Sztanke","year":"2006","journal-title":"Eur J Med Chem"},{"issue":"11","key":"10.1016\/j.bioorg.2021.104965_b0240","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1016\/j.ejmech.2009.05.031","article-title":"Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents","volume":"44","author":"El-Sayed Ali","year":"2009","journal-title":"Eur J Med Chem"},{"issue":"3","key":"10.1016\/j.bioorg.2021.104965_b0245","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1515\/hc-2015-0190","article-title":"Benzo[e][1,2,4]triazino[2,3-c][1,2,3]triazin-2-ones electro-deficient heterocyclic compounds with promising anticancer activity","volume":"22","author":"Voskoboynik","year":"2016","journal-title":"Heterocyclic Communications"},{"issue":"11","key":"10.1016\/j.bioorg.2021.104965_b0250","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2174\/1570180815666180727114216","article-title":"Synthesis, Anti-proliferative Evaluation, and Molecular Docking Studies of 3-(alkylthio)-5,6-diaryl-1,2,4-triazines as Tubulin Polymerization Inhibitors","volume":"16","author":"Farhad","year":"2019","journal-title":"Letters in Drug Design & Discovery"},{"key":"10.1016\/j.bioorg.2021.104965_b0255","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejmech.2017.07.073","article-title":"Novel 4\/3-((4-oxo-5-(2-oxoindolin-3-ylidene) thiazolidin-2-ylidene) amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies","volume":"139","author":"Eldehna","year":"2017","journal-title":"European journal of medicinal chemistry"},{"issue":"5","key":"10.1016\/j.bioorg.2021.104965_b0260","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1039\/C9RA10094F","article-title":"Design, eco-friendly synthesis, molecular modeling and anticancer evaluation of thiazol-5 (4 H)-ones as potential tubulin polymerization inhibitors targeting the colchicine binding site","volume":"10","author":"El-Naggar","year":"2020","journal-title":"RSC Advances"},{"key":"10.1016\/j.bioorg.2021.104965_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103422","article-title":"Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4 (3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers","volume":"94","author":"Mahdy","year":"2020","journal-title":"Bioorganic Chemistry"},{"issue":"12","key":"10.1016\/j.bioorg.2021.104965_b0270","doi-asserted-by":"crossref","first-page":"1900178","DOI":"10.1002\/ardp.201900178","article-title":"Benzoxazole\/benzothiazole-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations","volume":"352","author":"El-Helby","year":"2019","journal-title":"Archiv der Pharmazie"},{"issue":"10","key":"10.1016\/j.bioorg.2021.104965_b0275","doi-asserted-by":"crossref","first-page":"1900113","DOI":"10.1002\/ardp.201900113","article-title":"Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR-2 inhibitors","volume":"352","author":"El-Helby","year":"2019","journal-title":"Archiv der Pharmazie"},{"key":"10.1016\/j.bioorg.2021.104965_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102944","article-title":"Design, synthesis and anticancer evaluation of thieno [2, 3-d] pyrimidine derivatives as dual EGFR\/HER2 inhibitors and apoptosis inducers","volume":"88","author":"Elmetwally","year":"2019","journal-title":"Bioorganic chemistry"},{"key":"10.1016\/j.bioorg.2021.104965_b0285","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bioorg.2018.06.017","article-title":"Design, synthesis and anticancer evaluation of 1H-pyrazolo [3, 4-d] pyrimidine derivatives as potent EGFRWT and EGFRT790M inhibitors and apoptosis inducers","volume":"80","author":"Gaber","year":"2018","journal-title":"Bioorganic chemistry"},{"key":"10.1016\/j.bioorg.2021.104965_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104059","article-title":"Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2, 4-dione derivatives targeting VEGFR-2 enzyme","author":"El-Adl","year":"2020","journal-title":"Bioorganic Chemistry"},{"key":"10.1016\/j.bioorg.2021.104965_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104807","article-title":"New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis","volume":"110","author":"Alsaif","year":"2021","journal-title":"Bioorganic Chemistry"},{"issue":"19","key":"10.1016\/j.bioorg.2021.104965_b0300","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1021\/jm050502t","article-title":"A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach","volume":"48","author":"Nguyen","year":"2005","journal-title":"Journal of medicinal chemistry"},{"issue":"11","key":"10.1016\/j.bioorg.2021.104965_b0305","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s11095-012-0828-z","article-title":"An overview of tubulin inhibitors that interact with the colchicine binding site","volume":"29","author":"Lu","year":"2012","journal-title":"Pharmaceutical research"},{"issue":"15","key":"10.1016\/j.bioorg.2021.104965_b0310","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4155\/fmc-2017-0100","article-title":"Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures","volume":"9","author":"Li","year":"2017","journal-title":"Future Medicinal Chemistry"},{"issue":"7","key":"10.1016\/j.bioorg.2021.104965_b0315","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/aps.2014.34","article-title":"Tubulin inhibitors: pharmacophore modeling, virtual screening and molecular docking","volume":"35","author":"Niu","year":"2014","journal-title":"Acta Pharmacologica Sinica"},{"issue":"12","key":"10.1016\/j.bioorg.2021.104965_b0320","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1016\/S0021-9258(19)69153-2","article-title":"Role of B-ring of colchicine in its binding to tubulin","volume":"256","author":"Ray","year":"1981","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.bioorg.2021.104965_b0325","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/j.bmcl.2006.02.010","article-title":"Synthesis and biological evaluation of B-ring modified colchicine and isocolchicine analogs","volume":"16","author":"Cifuentes","year":"2006","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"24","key":"10.1016\/j.bioorg.2021.104965_b0330","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1021\/jm301151t","article-title":"Synthesis and Biological Evaluation of Colchicine B-Ring Analogues Tethered with Halogenated Benzyl Moieties","volume":"55","author":"Cosentino","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"issue":"04","key":"10.1016\/j.bioorg.2021.104965_b0335","first-page":"456","article-title":"Thieme Chemistry Journals Awardees \u2013 Where Are They Now?A Cascade Synthesis of 1,2,4-Triazin-3(2H)-ones Using Nitrogen-Substituted Isocyanates","volume":"13","author":"Dahab","year":"2017","journal-title":"Synlett"},{"issue":"1","key":"10.1016\/j.bioorg.2021.104965_b0340","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1039\/C5SC03197D","article-title":"Cascade reactions of nitrogen-substituted isocyanates: a new tool in heterocyclic chemistry","volume":"7","author":"Vincent-Rocan","year":"2016","journal-title":"Chemical Science"},{"issue":"91","key":"10.1016\/j.bioorg.2021.104965_b0345","doi-asserted-by":"crossref","first-page":"16405","DOI":"10.1039\/C5CC07212C","article-title":"Diversity-oriented heterocyclic synthesis using divergent reactivity of N-substituted iso(thio)cyanates","volume":"51","author":"Vincent-Rocan","year":"2015","journal-title":"Chemical Communications"},{"issue":"39","key":"10.1016\/j.bioorg.2021.104965_b0350","doi-asserted-by":"crossref","first-page":"16111","DOI":"10.1021\/ja305491t","article-title":"A Tunable Route for the Synthesis of Azomethine Imines and \u03b2-Aminocarbonyl Compounds from Alkenes","volume":"134","author":"Clavette","year":"2012","journal-title":"Journal of the American Chemical Society"},{"issue":"19","key":"10.1016\/j.bioorg.2021.104965_b0355","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1021\/acs.orglett.5b02464","article-title":"One-Pot Synthesis of Aza-Diketopiperazines Enabled by Controlled Reactivity of N-Isocyanate Precursors","volume":"17","author":"Ivanovich","year":"2015","journal-title":"Org Lett"},{"issue":"4","key":"10.1016\/j.bioorg.2021.104965_b0360","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/acs.orglett.5b03590","article-title":"Divergent Reactivity of N-Isocyanates with Primary and Secondary Amines: Access to Pyridazinones and Triazinones","volume":"18","author":"Derasp","year":"2016","journal-title":"Org Lett"},{"issue":"14","key":"10.1016\/j.bioorg.2021.104965_b0365","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1021\/acs.orglett.6b01686","article-title":"Copper-Catalyzed Cascade Substitution\/Cyclization of N-Isocyanates: A Synthesis of 1-Aminobenzimidazolones","volume":"18","author":"An","year":"2016","journal-title":"Org Lett"},{"issue":"15","key":"10.1016\/j.bioorg.2021.104965_b0370","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1021\/acs.orglett.6b01788","article-title":"Synthesis of Cyclic Azomethine Imines by Cycloaddition Reactions of N-Isocyanates and N-Isothiocyanates","volume":"18","author":"Bongers","year":"2016","journal-title":"Org Lett"},{"issue":"21","key":"10.1016\/j.bioorg.2021.104965_b0375","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1055\/s-0036-1588066","article-title":"N-Isocyanates, N-Isothiocyanates and Their Masked\/Blocked Derivatives: Synthesis and Reactivity","volume":"48","author":"Vincent-Rocan","year":"2016","journal-title":"Synthesis"},{"issue":"2","key":"10.1016\/j.bioorg.2021.104965_b0380","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1021\/acs.joc.6b02713","article-title":"Intermolecular Aminocarbonylation of Alkenes using Concerted Cycloadditions of Iminoisocyanates","volume":"82","author":"Bongers","year":"2017","journal-title":"The Journal of Organic Chemistry"},{"issue":"18","key":"10.1016\/j.bioorg.2021.104965_b0385","doi-asserted-by":"crossref","first-page":"9890","DOI":"10.1021\/acs.joc.7b01607","article-title":"Synthesis of Indazolones via Friedel-Crafts Cyclization of Blocked (Masked) N-Isocyanates","volume":"82","author":"Elkaeed","year":"2017","journal-title":"The Journal of Organic Chemistry"},{"issue":"12","key":"10.1016\/j.bioorg.2021.104965_b0390","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1016\/j.ejmech.2011.10.030","article-title":"Synthesis and kinetic testing of new inhibitors for a metallo-\u03b2-lactamase from Klebsiella pneumonia and Pseudomonas aeruginosa","volume":"46","author":"Mohamed","year":"2011","journal-title":"European journal of medicinal chemistry"},{"issue":"12","key":"10.1016\/j.bioorg.2021.104965_b0395","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1021\/acs.orglett.5b01281","article-title":"Synthesis of Multiple-Substituted Pyrroles via Gold(I)-Catalyzed Hydroamination\/Cyclization Cascade","volume":"17","author":"Li","year":"2015","journal-title":"Org Lett"},{"issue":"16","key":"10.1016\/j.bioorg.2021.104965_b0400","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1021\/ol4016089","article-title":"A Practical Approach to Semicarbazone and Hydrazone Derivatives via Imino-isocyanates","volume":"15","author":"Garland","year":"2013","journal-title":"Organic Letters"},{"issue":"1","key":"10.1016\/j.bioorg.2021.104965_b0405","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"Journal of Immunological Methods"},{"issue":"11","key":"10.1016\/j.bioorg.2021.104965_b0410","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.2042-7158.1997.tb06055.x","article-title":"Screening of hepatoprotective plant components using a HepG2 cell cytotoxicity assay","volume":"49","author":"Thabrew","year":"1997","journal-title":"J Pharm Pharmacol"},{"issue":"6395","key":"10.1016\/j.bioorg.2021.104965_b0415","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/359533a0","article-title":"Microtubule-motor activity of a yeast centromere-binding protein complex","volume":"359","author":"Hyman","year":"1992","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.bioorg.2021.104965_b0420","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/2213988501408010016","article-title":"Establishing a High-content Analysis Method for Tubulin Polymerization to Evaluate Both the Stabilizing and Destabilizing Activities of Compounds","volume":"8","author":"Sum","year":"2014","journal-title":"Current chemical genomics and translational medicine"},{"issue":"2","key":"10.1016\/j.bioorg.2021.104965_b0425","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1039\/C7MD00416H","article-title":"Molecular modeling study, synthesis and biological evaluation of combretastatin A-4 analogues as anticancer agents and tubulin inhibitors","volume":"9","author":"Quan","year":"2018","journal-title":"MedChemComm"},{"issue":"17","key":"10.1016\/j.bioorg.2021.104965_b0430","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1021\/jm049802l","article-title":"Concise Synthesis and Structure\u2212Activity Relationships of Combretastatin A-4 Analogues, 1-Aroylindoles and 3-Aroylindoles, as Novel Classes of Potent Antitubulin Agents","volume":"47","author":"Liou","year":"2004","journal-title":"Journal of Medicinal Chemistry"},{"issue":"6","key":"10.1016\/j.bioorg.2021.104965_b0435","doi-asserted-by":"crossref","first-page":"e2247","DOI":"10.1038\/cddis.2016.138","article-title":"Erianin induces G2\/M-phase arrest, apoptosis, and autophagy via the ROS\/JNK signaling pathway in human osteosarcoma cells in vitro and in vivo","volume":"7","author":"Wang","year":"2016","journal-title":"Cell Death & Disease"},{"issue":"5","key":"10.1016\/j.bioorg.2021.104965_b0440","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1242\/jcs.113.5.753","article-title":"Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies","volume":"113","author":"Wang","year":"2000","journal-title":"J Cell Sci"},{"issue":"7","key":"10.1016\/j.bioorg.2021.104965_b0445","first-page":"1391","article-title":"Apoptosis, p53, and tumor cell sensitivity to anticancer agents","volume":"59","author":"Brown","year":"1999","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.bioorg.2021.104965_b0450","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.24064","article-title":"Tumor resistance to apoptosis","volume":"124","author":"Fulda","year":"2009","journal-title":"International Journal of Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2021.104965_b0455","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1021\/ic701735q","article-title":"Luminescent biological probes derived from ruthenium (II) estradiol polypyridine complexes","volume":"47","author":"Lo","year":"2008","journal-title":"Inorganic Chemistry"},{"key":"10.1016\/j.bioorg.2021.104965_b0460","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semcdb.2017.11.036","article-title":"When dying is not the end: Apoptotic caspases as drivers of proliferation","volume":"82","author":"P\u00e9rez-Garijo","year":"2018","journal-title":"Seminars in Cell & Developmental Biology"},{"issue":"6","key":"10.1016\/j.bioorg.2021.104965_b0465","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008672","article-title":"Cellular mechanisms controlling caspase activation and function","volume":"5","author":"Parrish","year":"2013","journal-title":"Cold Spring Harbor perspectives in biology"},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2021.104965_b0470","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/B:MCBI.0000009865.70898.36","article-title":"Mitochondria and the Bcl-2 family proteins in apoptosis signaling pathways","volume":"256\u2013257","author":"Antonsson","year":"2004","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"10.1016\/j.bioorg.2021.104965_b0475","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1747-0285.2009.00791.x","article-title":"QSAR studies of CYP2D6 inhibitor aryloxypropanolamines using 2D and 3D descriptors","volume":"73","author":"Roy","year":"2009","journal-title":"Chemical biology & drug design"},{"issue":"1","key":"10.1016\/j.bioorg.2021.104965_b0480","first-page":"21","article-title":"QSAR models for the prediction of plasma protein binding","volume":"3","author":"Ghafourian","year":"2013","journal-title":"BioImpacts: BI"},{"issue":"2","key":"10.1016\/j.bioorg.2021.104965_b0485","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability","volume":"89","author":"Denizot","year":"1986","journal-title":"Journal of immunological methods"},{"key":"10.1016\/j.bioorg.2021.104965_b0490","doi-asserted-by":"crossref","unstructured":"Thabrew, M.I., R.D. HUGHES, and I.G. MCFARLANE, Screening of hepatoprotective plant components using a HepG2 cell cytotoxicity assay. Journal of pharmacy and pharmacology, 1997. 49(11): p. 1132-1135.","DOI":"10.1111\/j.2042-7158.1997.tb06055.x"},{"issue":"14","key":"10.1016\/j.bioorg.2021.104965_b0495","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"Journal of computational chemistry"},{"key":"10.1016\/j.bioorg.2021.104965_b0500","unstructured":"Themo Fisher Scientific, Invitrogen Caspase 3 (Cleaved) Human ELISA Kit. Jan. 2020]; Available from: https:\/\/www.thermofisher.com\/elisa\/product\/Caspase-3-Cleaved-Human-ELISA-Kit\/KHO1091."},{"key":"10.1016\/j.bioorg.2021.104965_b0505","unstructured":"Themo Fisher Scientific, Invitrogen Caspase 9 Human ELISA Kit ELISA Kit. Jan. 2020]; Available from: https:\/\/www.thermofisher.com\/elisa\/product\/Caspase-9-Human-ELISA-Kit\/BMS2025."},{"issue":"1","key":"10.1016\/j.bioorg.2021.104965_b0510","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5045\/br.2018.53.1.53","article-title":"Investigation of BAX and BCL2 expression and apoptosis in a resveratrol-and prednisolone-treated human T-ALL cell line","volume":"53","author":"Khanzadeh","year":"2018","journal-title":"CCRF-CEM. Blood research"},{"key":"10.1016\/j.bioorg.2021.104965_b0515","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molstruc.2018.04.010","article-title":"Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors","volume":"1166","author":"El-Gamal","year":"2018","journal-title":"Journal of Molecular Structure"},{"issue":"17","key":"10.1016\/j.bioorg.2021.104965_b0520","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1016\/j.bmc.2017.07.015","article-title":"Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4 (3H)-one derivatives as potential PPAR\u03b3 and SUR agonists","volume":"25","author":"Ibrahim","year":"2017","journal-title":"Bioorganic & medicinal chemistry"},{"key":"10.1016\/j.bioorg.2021.104965_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103115","article-title":"Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPAR\u03b3 and SUR agonists","volume":"91","author":"El-Zahabi","year":"2019","journal-title":"Bioorganic chemistry"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821003424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821003424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:24:23Z","timestamp":1758615863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821003424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":105,"alternative-id":["S0045206821003424"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.104965","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.104965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104965"}}